Skip to main content

Author: Dagny Stuart

Mathis strives to make her cancer journey meaningful

Nov. 9, 2017—Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast.

Read more

Reporter


Art donation to benefit VICC Radiation Oncology patients

Nov. 9, 2017—An artist with strong ties to Nashville has donated artwork to Vanderbilt-Ingram Cancer Center’s (VICC) Radiation Oncology department for the benefit of patients, both young and old.

Read more

Reporter


Lung cancer survivors and caregivers invited to VUMC event Nov. 16

Nov. 3, 2017—Lung cancer survivors and their caregivers are invited to attend a free educational evening at Vanderbilt University Medical Center (VUMC) Thursday, Nov. 16, 5:30 – 8:30 p.m., at the University Club, 2402 Garland Ave.

Read more

myVU myVU Take Note Reporter


Liquid biopsies help reveal lung cancer mutations

Nov. 2, 2017—Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center (VICC) have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC).

Read more

Reporter


Study to test combination therapy for breast cancer

Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

Read more

Health and Medicine Reporter Research


My Cancer Genome launches new search tool for clinical trials

Oct. 26, 2017—Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients.

Read more

Reporter


New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research

Oct. 26, 2017—A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations.

Read more

Health and Medicine myVU myVU News Research


Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR T therapy

Oct. 25, 2017—Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.

Read more

Reporter


Symposium honors Moses’ storied cancer research career

Oct. 19, 2017—Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.

Read more

Reporter


VICC investigators land support from Komen Foundation

Sep. 28, 2017—Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.

Read more

Health and Medicine Reporter Research Research Blog


Special symposium to honor Moses’ cancer research contributions is Oct. 11

Sep. 21, 2017—A research symposium honoring the career of Harold (Hal) Moses, M.D., who founded and served as director emeritus of Vanderbilt-Ingram Cancer Center, has been slated for Wednesday, Oct. 11, 7:45 a.m. – 3:30 p.m., at the Vanderbilt Student Life Center.

Read more

myVU myVU News Reporter


Vanderbilt to host symposium on bone marrow disorders

Sep. 14, 2017—Vanderbilt University Medical Center (VUMC) clinicians will host an educational symposium on bone marrow disorders, including bone marrow failure, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), on Friday, Oct. 13, from 11:30 a.m. – 6 p.m. at the Omni Nashville Hotel, 250 5th Ave. South.

Read more

myVU myVU Take Note Reporter


Page 1 of 2812345678...Last »